A medical research company in County Kerry has stared clinical trials of a new drug to find a treatment for Autism Spectrum ...

Cognito Therapeutics, a pioneering neurotechnology company developing disease-modifying therapies for neurodegenerative diseases, today announced key executive appointments designed to accelerate the ...

GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Surescripts®, the nation's leading health information network, unveils the first-of-its-kind Touchless Prior Authorization technology, transforming prior authorizations to help alleviate one of ...

Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

They are often tasked as a pharmacy representative to pharmacy and therapeutics (P&T ... they do maintain a database of clinical studies, both published and unpublished, that provides hard ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as ...

The town of Havana, Florida, is seeking a family doctor to practice in the rural community. Incentives include rent-free office space with medical equipment owned by the town. With a physician ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.3cY8rBmp.js ...

Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERT™ platform. In return, ...

MaxCyte ( NASDAQ: MXCT) Wednesday said that it had entered into a strategic platform license with TG Therapeutics, a fully integrated, commercial-stage, biopharmaceutical company focused on the ...

NIH funding cuts would mean universities would have to find ways to make cutbacks and could result in “massive layoffs” ...